Jain Global’s Puma Biotechnology PBYI Stock Holding History

Jain Global’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,871	Closed	-$36.2K	–	1274
2024 Q4	$36.2K	Buy	+11,871	New	+$34.5K	﹤0.01%	716

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jain Global's PBYI Position: Q1 2025 in Review

Jain Global sold out of Puma Biotechnology (PBYI) in Q1 2025, closing a stake of 11,871 shares — an estimated $36.2K sold.

Jain Global first reported a position in PBYI in Q4 2024 and held it in 1 quarter. The position peaked at $36.2K in Q4 2024. 116 funds tracked by Wall St. Rank hold PBYI as of Q1 2025.

Jain Global reported no remaining Puma Biotechnology position as of Q1 2025 after selling out during the quarter.
Jain Global sold 11,871 Puma Biotechnology shares in Q1 2025, an estimated $36.2K.
Jain Global first reported a position in Puma Biotechnology in Q4 2024 and held it in 1 quarter.
Jain Global's Puma Biotechnology position peaked at $36.2K in Q4 2024.
116 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2025.

Based on Jain Global's 13F filing for Q1 2025, filed 15 May 2025.